NCT05517161 is a clinical trial of INSIGHT in Communication Disorder, Social, sponsored by Moravian University.

Who is sponsoring NCT05517161?

NCT05517161 is sponsored by Moravian University.

What drugs are being tested in NCT05517161?

Interventions in NCT05517161: INSIGHT.

What condition does NCT05517161 study?

NCT05517161 studies Communication Disorder, Social.

Is NCT05517161 still recruiting?

NCT05517161 is currently completed. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT05517161

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Roll for Intervention - TBI Group Treatment

Completed Last updated 23 October 2023

What this trial tests

trial testing INSIGHT in Communication Disorder, Social in 5 participants. Completed in 1 May 2023.

Timeline

2 May 2022

Primary endpoint
20 December 2022

1 May 2023

Quick facts

Lead sponsor	Moravian University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5
Start date	2 May 2022
Primary completion	20 December 2022
Estimated completion	1 May 2023
Sites	1 location across United States

Drugs / interventions tested

INSIGHT

Conditions studied

Communication Disorder, Social — all drugs for Communication Disorder, Social →

Sponsor

Moravian University

Who can join

Adults 18 to 65, any sex, with Communication Disorder, Social. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Communication group intervention for individuals with Traumatic Brain Injury based on INSIGHT protocol (Keegan et al, 2020) with roll playing game focus

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Moravian University trials

Trials by the same sponsor.

NCT05519891 — 3D Printed Assistive Devices for Individuals With Physical Disabilities · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05517161 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moravian University
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing